1. Home
  2. RGNX vs MITK Comparison

RGNX vs MITK Comparison

Compare RGNX & MITK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo REGENXBIO Inc.

RGNX

REGENXBIO Inc.

HOLD

Current Price

$8.05

Market Cap

793.5M

Sector

Health Care

ML Signal

HOLD

Logo Mitek Systems Inc.

MITK

Mitek Systems Inc.

HOLD

Current Price

$16.72

Market Cap

723.9M

Sector

Technology

ML Signal

HOLD

Company Overview

Basic Information
Metric
RGNX
MITK
Founded
2008
1983
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Computer peripheral equipment
Sector
Health Care
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
793.5M
723.9M
IPO Year
2015
1995

Fundamental Metrics

Financial Performance
Metric
RGNX
MITK
Price
$8.05
$16.72
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
8
1
Target Price
$28.75
$15.00
AVG Volume (30 Days)
1.3M
583.5K
Earning Date
05-05-2026
05-07-2026
Dividend Yield
N/A
N/A
EPS Growth
18.08
171.43
EPS
N/A
0.43
Revenue
$10,393,000.00
$45,390,000.00
Revenue This Year
$51.21
$9.55
Revenue Next Year
$19.08
$8.07
P/E Ratio
N/A
$40.35
Revenue Growth
126.48
N/A
52 Week Low
$5.46
$8.53
52 Week High
$16.19
$21.05

Technical Indicators

Market Signals
Indicator
RGNX
MITK
Relative Strength Index (RSI) 37.32 40.31
Support Level $7.82 $16.37
Resistance Level $9.67 $17.97
Average True Range (ATR) 0.44 0.68
MACD -0.07 -0.12
Stochastic Oscillator 20.47 7.99

Price Performance

Historical Comparison
RGNX
MITK

About RGNX REGENXBIO Inc.

Regenxbio Inc is a clinical-stage biotechnology company focused on the development of gene therapy treatments. Its product candidates are designed to deliver genes to cells to address genetic defects or enable the production of therapeutic proteins. The company is developing a pipeline of investigational gene therapy treatments using its NAV Technology Platform based on adeno-associated virus (AAV) vectors. Its internal research and development programs are focused on therapies for retinal, neuromuscular, and neurodegenerative diseases.

About MITK Mitek Systems Inc.

Mitek Systems Inc is engaged in the development, sale, and service of proprietary software solutions related to mobile imaging. The firm is a software development company with expertise in artificial intelligence, and machine learning. It serves more than 7,900 financial services organizations, financial technology (fintech) brands, telecommunications companies, and marketplace brands across the globe. The company's Mobile Deposit solution is used by consumers for mobile check deposits. The company's Mobile Verify verifies a user's identity online, enabling organizations to build safer digital communities, whereas CheckReader enables financial institutions to automatically extract data from a check image received across any deposit channel - branch, ATM, RDC, and mobile.

Share on Social Networks: